0000000000646754

AUTHOR

Albino Lo Coco

showing 4 related works from this author

The amyotrophic lateral sclerosis functional rating scale predicts survival time in amyotrophic lateral sclerosis patients on invasive mechanical ven…

2007

Objective: To determine whether the amyotrophic lateral sclerosis functional rating scale (ALSFRS), which is a validated instrument that assesses the functional status and the disease progression in patients with amyotrophic lateral sclerosis (ALS), predicts hospital length of stay and survival time in ALS patients treated with tracheostomy-intermittent positive-pressure ventilation (TIPPV). Methods: Thirty-three consecutive ALS patients with acute respiratory failure who received therapy with TIPPV were prospectively followed up from their admission to the hospital until death. The association of ALSFRS score at hospital admission with length of hospital stay and survival after TIPPV were …

Pulmonary and Respiratory MedicineArtificial ventilationMalemedicine.medical_specialtymedicine.medical_treatmentCritical Care and Intensive Care MedicineSeverity of Illness Indexlaw.inventionIntermittent Positive-Pressure VentilationlawPredictive Value of TestsInternal medicineSickness Impact ProfileSeverity of illnessmedicineHumansProspective StudiesProspective cohort studyAgedProportional Hazards ModelsMechanical ventilationProportional hazards modelbusiness.industryHazard ratioAmyotrophic Lateral SclerosisLength of StayMiddle AgedPrognosisIntensive care unitSurgeryRespiratory failureAcute DiseaseDisease ProgressionSettore MED/26 - NeurologiaFemaleCardiology and Cardiovascular MedicinebusinessRespiratory InsufficiencyChest
researchProduct

Noninvasive Positive Pressure Ventilation in Amyotrophic Lateral Sclerosis

2010

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease of unknown origin that affects approximately 1.5 individuals per 100,000 every year; usually, these individuals are between 55 and 75 years of age [1]. ALS causes progressive weakness of voluntary muscle groups, including respiratory ones, and respiratory failure or pneumonia related to respiratory muscle weakness is the most frequent cause of death.

medicine.medical_specialtyWeaknessbusiness.industryDiseasemedicine.diseasePneumoniaRespiratory failureInternal medicinemedicineCardiologyRespiratory systemAmyotrophic lateral sclerosismedicine.symptombusinessPositive pressure ventilationCause of death
researchProduct

Development of chronic hypoventilation in amyotrophic lateral sclerosis patients

2006

SummaryEarly prediction of respiratory muscle involvement and chronic hypoventilation (CH) in amyotrophic lateral sclerosis (ALS) patients can help to plan mechanical ventilatory aids and palliative care interventions well before respiratory failure occurs. To describe the natural history of the progressive pulmonary dysfunction leading to CH, and to identify potential parameters associated with its development in ALS, we prospectively followed 38 ALS patients up to 26 months, starting from their first presentation at our Clinic. At study entry, median FVC was 87% (interquartile range: 72–104%) and declined by 10% after 6 months (range: 2–49%), showing a very high inter-patient variability.…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyPalliative caremedicine.medical_treatmentVital CapacityFEV1/FVC ratiodisease progressionPatient Education as TopicInterquartile rangeInternal medicinemedicineRespiratory muscleHumansamyotrophic lateral sclerosiProspective StudiesAmyotrophic lateral sclerosisProspective cohort studyLungAgedProportional Hazards ModelsMechanical ventilationbusiness.industryAmyotrophic Lateral SclerosisPalliative CareAge FactorsHypoventilationMiddle Agedmedicine.diseaseRespiration ArtificialRespiratory MusclesFVCSurgeryRespiratory failureChronic DiseaseFemalebusinesschronic hypoventilationAppel ALS Rating ScaleRespiratory Medicine
researchProduct

Outcome and attitudes toward home tracheostomy ventilation of consecutive patients: a 10-year experience.

2008

Summary Objectives To describe survival, predictors of long-term outcome and attitudes in patients treated at home by tracheostomy-intermittent positive-pressure ventilation (TIPPV) for respiratory failure during a 10-year period (1995–2004). Methods Seventy-seven consecutive patients were treated by TIPPV at home. Patients were divided into three groups: neuromuscular, pulmonary, and non-pulmonary patients. Effects of TIPPV on survival, factors influencing outcome after TIPPV, and attitudes of patients and caregivers regarding mechanical ventilation were studied. Results Forty-one patients (53%) were neuromuscular, 19 (25%) were affected by pulmonary diseases, and 17 (22%) by non-pulmonary…

Artificial ventilationPulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtySurvivalHome Nursingmedicine.medical_treatmentRespiratory failureIntermittent Positive-Pressure VentilationPulmonary Disease Chronic ObstructiveTracheotomyTracheostomyInternal medicinemedicineCOPDHumansProspective StudiesProspective cohort studySurvival rateAgedMechanical ventilationAged 80 and overCOPDbusiness.industryTracheostomy mechanical ventilationRespiratory diseaseAmyotrophic Lateral SclerosisNeuromuscular DiseasesMiddle Agedmedicine.diseaseRespiration ArtificialSurgerySurvival RateCaregiversRespiratory failureFemaleALSbusinessRespiratory InsufficiencyAttitude to HealthRespiratory medicine
researchProduct